Allianz Asset Management GmbH - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$887,000
-55.0%
155,085
-28.1%
0.00%0.0%
Q4 2021$1,972,000
-8.7%
215,644
+134.5%
0.00%
-50.0%
Q4 2019$2,161,000
-16.1%
91,948
-33.0%
0.00%
-33.3%
Q3 2019$2,575,000
-17.5%
137,208
-18.3%
0.00%0.0%
Q2 2019$3,122,000
-88.6%
167,953
-85.0%
0.00%
-88.9%
Q1 2019$27,324,000
-0.5%
1,117,985
+4.9%
0.03%
-10.0%
Q4 2018$27,459,000
-54.0%
1,066,263
-43.5%
0.03%
-44.4%
Q3 2018$59,736,000
+829.3%
1,887,391
+1040.8%
0.05%
+800.0%
Q2 2018$6,428,000
+115.8%
165,444
+53.3%
0.01%
+100.0%
Q1 2018$2,979,000
+50.2%
107,926
-1.5%
0.00%
+50.0%
Q4 2017$1,983,000
+11.9%
109,591
-0.1%
0.00%0.0%
Q3 2017$1,772,000
+16.5%
109,708
+0.0%
0.00%
+100.0%
Q2 2017$1,521,000
+8.0%
109,657
+17.6%
0.00%0.0%
Q1 2017$1,408,000
+14.9%
93,228
-0.3%
0.00%0.0%
Q4 2016$1,225,000
-57.5%
93,528
-44.3%
0.00%
-66.7%
Q3 2016$2,880,000
-25.8%
167,969
-21.8%
0.00%
-25.0%
Q2 2016$3,879,000
-56.8%
214,891
-54.5%
0.00%
-60.0%
Q1 2016$8,976,000
-26.5%
472,678
+5.8%
0.01%
-28.6%
Q4 2015$12,220,000
+219.1%
446,891
+184.7%
0.01%
+180.0%
Q3 2015$3,829,000
-72.4%
156,955
-83.6%
0.01%
-68.8%
Q1 2015$13,892,000954,7800.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders